Reply to the Letter: "Low levels of transaminase and mortality risk in older people with special reference to sarcopenia"

Aging Clin Exp Res. 2022 Jan;34(1):217. doi: 10.1007/s40520-021-02023-6. Epub 2021 Nov 16.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Aged
  • Geriatric Assessment
  • Humans
  • Sarcopenia* / mortality
  • Transaminases

Substances

  • Transaminases